Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down
Surgery and Radiation therapy remain gold standard treatments for prostate cancer. Continued improvements in technique and technology further reduce the side effects associated with these very effective treatments.

PROGRAM

  1. Welcome and Introduction - Dr. Preston Sprenkle (USA)
  2. Cancer control outcomes. Radiotherapy - Dr. Elisha Fredman (Israel)
  3. Cancer control outcomes. Robot versus Radiotherapy - Dr. Preston Sprenkle (USA)
  4. Adjuvant radiotherapy - Dr. Suneil Jain (Ireland)
  5. Treatment-related adverse events. Robotic Prostatectomy - Dr. Preston Sprenkle (USA)
  6. Treatment-related adverse events. Robot versus Radiotherapy - Dr. James Yu (USA)
  7. Discussion, closing and remarks - All faculty moderated by Dr. Preston Sprenkle (USA)
Faculty keyboard_arrow_down
Dr. Preston C. Sprenkle MD, Associate Professor of Urology; Co-Chair, Cancer Liaison Committee, Oncology, Co-Chair, NCCN Guidelines Committee on Prostate Cancer Early Detection, Division Chief, Division of Urology at VA Connecticut Healthcare System, Urology, Director, Urology Research Fellowship, Yale University Urology
Dr. Elisha Fredman Genitourinary Radiation Oncology Team Leader, Director of Research and Innovation, Davidoff Cancer Center, Rabin Medical Center, Israel Surgical Oncology
Dr. Suneil Jain Professor and Honorary Consultant in Clinical Oncology at Queen's University Belfast, Ireland Surgical Oncology
Dr. James Yu Professor and Executive Vice Chair, Department of Radiation Oncology, Columbia University Irving Medical Center, USA Surgical Oncology
Devices keyboard_arrow_down
Related Content keyboard_arrow_down